ArticleHeliyon2023

Prediction of disease-free survival of N1/2 non-small cell lung cancer after adjuvant chemotherapy by the biomarker RPMB.

Ning An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.